Known and novel fusion detection and research via amplicon-based target enrichment for Next Generation Sequencing (NGS) on Illumina sequencing platforms

• OmniFusion™ RNA Lung Cancer Panel uses single primer amplification method to enables detection more than 530 known and unknown fusions associated with non-small cell lung cancer.

• Fusion genes include 11 cancer driver genes ( ALK, CIT, MBIP, MET, NRG1, NTRK1, NTRK3, PDGFRA, RET, ROS1, TACC3). OmniFusion workflow allows detection of novel fusion partners and and splicing variants.

• Compared to other methods such as qPCR, FISH, or Sanger sequencing, Paragon Genomics targeted fusion sequencing method allows robust multiplexed detection of variants using minimum sample input and a simple workflow.